Rapid detection biosensor; collection to detection in 20 minutes.
NanoSpy, Inc. was founded in 2017 to establish the new state-of-the-art in rapid pathogen detection. Using proprietary and patent-pending technologies, we leverage our expertise in biomedical engineering, microbiology, nanomaterials, and mechanical engineering to dramatically simplify the detection process with a new paradigm in biosensor platforms. Sensitivity, specificity, and speed now are combined in one convenient test that delivers results fast! In 20 minutes, NanoSpy biosensors can detect a single targeted pathogen at 5 CFU/mL or less from common buffer samples taken right at the point of detection.No time-consuming enrichment process.No environmentally hazardous reagents.No laboratory requirements.Translation:No time wasted.No decisions delayed.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 29, 2022 | Grant | — | 1 | Iowa G2M Accelerator | — | Detail |
Aug 15, 2021 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Iowa G2M Accelerator | Yes | Grant |
National Science Foundation | Yes | Grant |